Comparison chlorambucil prednisone versus cyclophosphamide vincristine prednisone initial treatment chronic lymphocytic leukemia long-term follow-up Eastern Cooperative Oncology Group clinical trial Eastern Cooperative Oncology Group ECOG study patients advanced chronic lymphocytic leukemia CLL regimen chlorambucil day prednisone mg days weeks intensive regimen cyclosphosphamide days vincristine IV day prednisone days CVP weeks Treatment months maximal response eligible patients CVP median follow-up years significant differences survival years complete remission CR rate duration response years CVP Toxicity modest prolonged treatment long median survival years stage III IV patients superior treatment response increase intensity therapy results comparable cyclophosphamide doxorubicin vincristine prednisone CHOP therapy investigators data suggest intermittent response standard treatment approach advanced CLL 